Summary
The National Institutes of Health (NIH) is soliciting investigator-initiated R21 exploratory/developmental research grant applications focused on innovation in computational genomics and data science. Clinical trials are explicitly not allowed under this funding opportunity. The R21 mechanism supports early-stage, high-risk/high-reward research projects in computational and data science approaches applied to genomics. This is a standing program announcement open from November 2024 through September 2027, inviting submissions on a rolling basis.